Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.05B |
| 2 |
Texas Instruments
TXN
|
+$1.69B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Starbucks
SBUX
|
+$1.2B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$949M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.77B |
| 2 |
Microsoft
MSFT
|
+$1.3B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.22B |
| 4 |
iShares US Real Estate ETF
IYR
|
+$1.11B |
| 5 |
Procter & Gamble
PG
|
+$915M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.33% |
| 2 | Consumer Discretionary | 7.25% |
| 3 | Financials | 7.18% |
| 4 | Communication Services | 6.16% |
| 5 | Healthcare | 5.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Liberty Live Group Series A
LLYVA
$9.16B
| $758K | ﹤0.01% |
20,197
-22,869
| -53% | -$856K |
|
|
CMBT
2677
CMB.TECH NV
CMBT
$4.76B
| $757K | ﹤0.01% |
45,758
-221,835
| -83% | -$3.77M |
|
2678
CALL
ChargePoint
CHPT
$152M
| $755K | ﹤0.01% |
+25,000
| New | +$814K |
|
2679
PMV Pharmaceuticals
PMVP
$62.9M
| $753K | ﹤0.01% |
464,952
-28,598
| -6% | -$51.6K |
|
2680
Relay Therapeutics
RLAY
$4.3B
| $752K | ﹤0.01% |
115,278
-24,718
| -18% | -$169K |
|
2681
1-800-Flowers.com
FLWS
$258M
| $750K | ﹤0.01% |
78,754
+9,652
| +14% | +$90.6K |
|
|
MRSN
2682
DELISTED
Mersana Therapeutics
MRSN
| $749K | ﹤0.01% |
14,909
-1,460
| -9% | -$106K |
|
|
XRN
2683
Chiron Real Estate Inc
XRN
$469M
| $748K | ﹤0.01% |
16,469
+5,466
| +50% | +$238K |
|
2684
Ethan Allen Interiors
ETD
$598M
| $746K | ﹤0.01% |
26,737
-13,872
| -34% | -$411K |
|
2685
Leslie's
LESL
$14.2M
| $743K | ﹤0.01% |
8,868
-4,673
| -35% | -$454K |
|
2686
QCR Holdings
QCRH
$1.71B
| $743K | ﹤0.01% |
12,375
-9,405
| -43% | -$538K |
|
2687
Ooma
OOMA
$588M
| $740K | ﹤0.01% |
74,562
+3,747
| +5% | +$29.8K |
|
2688
Mobileye
MBLY
$2.13B
| $740K | ﹤0.01% |
26,352
-4,791
| -15% | -$139K |
|
2689
CALL
Maplebear
CART
$10.6B
| $739K | ﹤0.01% |
23,000
+200
| +0.9% | +$6.88K |
|
|
SPTN
2690
DELISTED
SpartanNash
SPTN
| $737K | ﹤0.01% |
39,271
-22,765
| -37% | -$444K |
|
2691
The RMR Group
RMR
$321M
| $736K | ﹤0.01% |
32,574
-7,479
| -19% | -$175K |
|
|
KE
2692
Kimball Electronics
KE
$635M
| $736K | ﹤0.01% |
33,478
-12,721
| -28% | -$277K |
|
2693
Nicolet Bankshares
NIC
$3.64B
| $735K | ﹤0.01% |
8,857
-8,139
| -48% | -$651K |
|
|
FFWM
2694
DELISTED
First Foundation Inc
FFWM
| $735K | ﹤0.01% |
112,266
-116,326
| -51% | -$713K |
|
2695
Portillo's
PTLO
$317M
| $734K | ﹤0.01% |
75,486
-9,549
| -11% | -$106K |
|
2696
Integra LifeSciences
IART
$1.33B
| $733K | ﹤0.01% |
25,167
-49,076
| -66% | -$1.46M |
|
2697
CALL
XPeng
XPEV
$11.2B
| $733K | ﹤0.01% |
+100,000
| New | +$789K |
|
2698
Sprout Social
SPT
$492M
| $733K | ﹤0.01% |
20,530
-27,503
| -57% | -$1.11M |
|
2699
Organon & Co
OGN
$3.56B
| $732K | ﹤0.01% |
35,347
-232,205
| -87% | -$4.61M |
|
2700
Arlo Technologies
ARLO
$1.68B
| $722K | ﹤0.01% |
55,392
-209,852
| -79% | -$2.61M |
|
Similar funds
Barclays's Q2 2024 Portfolio in Review
As of Q2 2024, Barclays held 5,455 positions worth $327B, up 14% from $288B the previous quarter. Its ten largest holdings account for 42% of the portfolio.
Barclays deployed $29.4B of net new capital in Q2 2024, opening 406 new positions and adding to 1,053 existing holdings. Its largest new stake was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $2.77B trimmed.
- Barclays's largest Q2 2024 buy was Ferrovial N.V. Ordinary Shares: 4,837,593 shares worth $186M.
- Barclays added most to CRH in Q2 2024, an estimated $2.05B increase.
- Barclays's biggest Q2 2024 reduction was Apple, cutting an estimated $2.77B.
- Barclays fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $212M.
- Barclays's ten largest holdings make up 42% of its $327B portfolio in Q2 2024.
- Barclays opened 406 new positions and closed 646 in Q2 2024.
- Barclays's portfolio value rose 14% quarter-over-quarter to $327B.
Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.